Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic Lesions
- 30 June 1998
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 110 (6), 932-938
- https://doi.org/10.1046/j.1523-1747.1998.00211.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.JCI Insight, 1996
- Non-radioactive localization of nucleic acids by direct in situ PCR and in situ RT-PCR in paraffin-embedded sections.Journal of Histochemistry & Cytochemistry, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22Science, 1992
- Homozygous deletions within human chromosome band 9p21 in melanoma.Proceedings of the National Academy of Sciences, 1992
- Modulation of growth in normal and malignant melanocytic cells by all‐trans retinoic acidJournal of Cutaneous Pathology, 1992
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneCell, 1988
- A study of tumor progression: The precursor lesions of superficial spreading and nodular melanomaHuman Pathology, 1984